Christina Morgenthaler, M.S.
Director Clinical Operations
Christina has diverse clinical operations experience at the site, vendor, and Sponsor levels of research. Prior to InCarda, Christina was at Gilead Sciences, where she led a global Phase 2 rheumatoid arthritis study. Prior to Gilead, Christina was at BioMarin supporting studies in oncology and rare diseases and at QuantifiCare, where she managed photography sub-studies across oncology, ABSSSI, psoriasis, and aesthetics. Christina also previously led data management and protocol compliance oversight activities for sarcoma, lung cancer, and Phase 1 solid tumor clinical trials as a Data Manager at UCLA.
Christina previously served on a Patient Advisory Board for Octopharma, currently serves on the Research Committee of the VWD Connect Foundation, and is co-Principal Investigator for the VWD Connect Foundation’s Severe Von Willebrand Disease Patient Registry.
Christina holds a B.S. in Geology from San Jose State University, an M.S. in Biotechnology from Johns Hopkins University, and an Executive M.B.A. from Quantic School of Business and Technology.